Home8QQ • FRA
add
AbCellera Biologics Inc
Nakaraang pagsara
€2.46
Sakop ng araw
€2.44 - €2.44
Sakop ng taon
€2.16 - €5.43
Market cap
845.69M USD
Average na Volume
413.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 7.32M | -27.18% |
Gastos sa pagpapatakbo | 59.85M | 139.67% |
Net na kita | -36.93M | -20.97% |
Net profit margin | -504.30 | -66.12% |
Kita sa bawat share | -0.13 | -18.18% |
EBITDA | -56.93M | -24.36% |
Aktuwal na % ng binabayarang buwis | 23.36% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 670.36M | -15.75% |
Kabuuang asset | 1.41B | -8.11% |
Kabuuang sagutin | 301.51M | -11.93% |
Kabuuang equity | 1.11B | — |
Natitirang share | 294.67M | — |
Presyo para makapag-book | 0.65 | — |
Return on assets | -16.25% | — |
Return on capital | -19.58% | — |
Cash Flow
Net change in cash
| (USD) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -36.93M | -20.97% |
Cash mula sa mga operasyon | -29.97M | -250.56% |
Cash mula sa pag-invest | 52.10M | 251.49% |
Cash mula sa financing | 2.65M | 532.70% |
Net change in cash | 24.74M | 286.42% |
Malayang cash flow | -42.55M | -1,686.49% |
Tungkol
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology firm that researches and develops human antibodies. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia. Wikipedia
CEO
Itinatag
2012
Headquarters
Website
Mga Empleyado
586
